{
  "CB1": {
    "name": "CB1",
    "type": "checkbox",
    "page": 2,
    "field_label": "Start of treatment",
    "question": "Is this a new treatment start for the patient?",
    "context": "Treatment timeline section. Indicates initiation of new therapy for patient. Dependent on CB5."
  },
  "T2": {
    "name": "T2",
    "type": "text",
    "page": 2,
    "field_label": "Start date: (MM)",
    "question": "What is the month of the treatment start date?",
    "context": "Treatment timeline section. Month of planned medication initiation for patient. Only if 'Start of treatment' selected."
  },
  "T3": {
    "name": "T3",
    "type": "text",
    "page": 2,
    "field_label": "Start date: (DD)",
    "question": "What is the day of the treatment start date?",
    "context": "Treatment timeline section. Day of planned medication initiation for patient. Only if 'Start of treatment' selected."
  },
  "T4": {
    "name": "T4",
    "type": "text",
    "page": 2,
    "field_label": "Start date: (YYYY)",
    "question": "What is the year of the treatment start date?",
    "context": "Treatment timeline section. Year of planned medication initiation for patient. Only if 'Start of treatment' selected."
  },
  "CB5": {
    "name": "CB5",
    "type": "checkbox",
    "page": 2,
    "field_label": "Continuation of therapy",
    "question": "Is this a continuation of therapy for the patient?",
    "context": "Treatment timeline section. Indicates ongoing therapy for patient. Dependent on CB1."
  },
  "T6": {
    "name": "T6",
    "type": "text",
    "page": 2,
    "field_label": "Date of last treatment: (MM)",
    "question": "What is the month of the patient's last treatment date?",
    "context": "Treatment timeline section. Month of most recent treatment for patient. Only if 'Continuation of therapy' selected."
  },
  "T7": {
    "name": "T7",
    "type": "text",
    "page": 2,
    "field_label": "Date of last treatment: (DD)",
    "question": "What is the day of the patient's last treatment date?",
    "context": "Treatment timeline section. Day of most recent treatment for patient. Only if 'Continuation of therapy' selected."
  },
  "T8": {
    "name": "T8",
    "type": "text",
    "page": 2,
    "field_label": "Date of last treatment: (YYYY)",
    "question": "What is the year of the patient's last treatment date?",
    "context": "Treatment timeline section. Year of most recent treatment for patient. Only if 'Continuation of therapy' selected."
  },
  "T9": {
    "name": "T9",
    "type": "text",
    "page": 2,
    "field_label": "Precertification Requested By:",
    "question": "Who is requesting this precertification?",
    "context": "General information section. Identifies the individual or entity submitting the prior authorization request."
  },
  "T10": {
    "name": "T10",
    "type": "text",
    "page": 2,
    "field_label": "Phone:",
    "question": "What is the phone number for the precertification requester?",
    "context": "General information section. Contact details for the precertification requester for follow-up."
  },
  "T11": {
    "name": "T11",
    "type": "text",
    "page": 2,
    "field_label": "Fax:",
    "question": "What is the fax number for the precertification requester?",
    "context": "General information section. Contact details for the precertification requester for document submission."
  },
  "T12": {
    "name": "T12",
    "type": "text",
    "page": 5,
    "field_label": "Patient First Name",
    "question": "What is the patient's first name?",
    "context": "Patient identification in the Patient Information section, essential for accurate record matching and verification."
  },
  "T13": {
    "name": "T13",
    "type": "text",
    "page": 5,
    "field_label": "Patient Last Name",
    "question": "What is the patient's last name?",
    "context": "Patient identification in the Patient Information section, crucial for accurate record matching and verification."
  },
  "T14": {
    "name": "T14",
    "type": "text",
    "page": 5,
    "field_label": "Patient DOB (MM/DD/YYYY)",
    "question": "What is the patient's date of birth (MM/DD/YYYY)?",
    "context": "Patient identification in the Patient Information section, vital for age-based criteria and accurate record matching."
  },
  "T15": {
    "name": "T15",
    "type": "text",
    "page": 2,
    "field_label": "Address:",
    "question": "What is the patient's street address?",
    "context": "Patient Information section. Required residential address for patient contact and records."
  },
  "T16": {
    "name": "T16",
    "type": "text",
    "page": 2,
    "field_label": "City:",
    "question": "What is the patient's city of residence?",
    "context": "Patient Information section. Required city for the patient's residential address."
  },
  "T17": {
    "name": "T17",
    "type": "text",
    "page": 2,
    "field_label": "State:",
    "question": "What is the patient's state of residence?",
    "context": "Patient Information section. Required state for the patient's residential address."
  },
  "T18": {
    "name": "T18",
    "type": "text",
    "page": 2,
    "field_label": "ZIP:",
    "question": "What is the patient's ZIP code?",
    "context": "Patient Information section. Required ZIP code for the patient's residential address."
  },
  "T19": {
    "name": "T19",
    "type": "text",
    "page": 5,
    "field_label": "Patient Phone",
    "question": "What is the patient's phone number?",
    "context": "Patient contact information in the Patient Information section for communication regarding the request."
  },
  "T20": {
    "name": "T20",
    "type": "text",
    "page": 2,
    "field_label": "Work Phone:",
    "question": "What is the patient's work phone number?",
    "context": "Patient Information section. Secondary contact phone number for the patient."
  },
  "T21": {
    "name": "T21",
    "type": "text",
    "page": 2,
    "field_label": "Cell Phone:",
    "question": "What is the patient's cell phone number?",
    "context": "Patient Information section. Mobile contact number for the patient."
  },
  "T22": {
    "name": "T22",
    "type": "text",
    "page": 2,
    "field_label": "E-mail:",
    "question": "What is the patient's email address?",
    "context": "Patient Information section. Electronic contact information for the patient."
  },
  "T24": {
    "name": "T24",
    "type": "text",
    "page": 2,
    "field_label": "lbs",
    "question": "What is the patient's current weight in pounds?",
    "context": "Patient Information section. Patient's current weight, used for medication dosing calculations."
  },
  "T25": {
    "name": "T25",
    "type": "text",
    "page": 2,
    "field_label": "kgs",
    "question": "What is the patient's current weight in kilograms?",
    "context": "Patient Information section. Patient's current weight, used for medication dosing calculations."
  },
  "T26": {
    "name": "T26",
    "type": "text",
    "page": 2,
    "field_label": "inches",
    "question": "What is the patient's height in inches?",
    "context": "Patient Information section. Patient's height, used for body surface area calculations for dosing."
  },
  "T27": {
    "name": "T27",
    "type": "text",
    "page": 2,
    "field_label": "cms",
    "question": "What is the patient's height in centimeters?",
    "context": "Patient Information section. Patient's height, used for body surface area calculations for dosing."
  },
  "T23": {
    "name": "T23",
    "type": "text",
    "page": 2,
    "field_label": "Allergies:",
    "question": "Does the patient have any known allergies? If so, please list them.",
    "context": "Patient Information section. Critical clinical information for patient safety and medication selection."
  },
  "T28": {
    "name": "T28",
    "type": "text",
    "page": 2,
    "field_label": "Member ID #:",
    "question": "What is the patient's insurance member ID number?",
    "context": "Insurance Information section. Primary identifier for the patient under their health plan."
  },
  "T29": {
    "name": "T29",
    "type": "text",
    "page": 2,
    "field_label": "Group #:",
    "question": "What is the patient's insurance group number?",
    "context": "Insurance Information section. Identifies the group policy the patient is covered under."
  },
  "T30": {
    "name": "T30",
    "type": "text",
    "page": 2,
    "field_label": "Insured:",
    "question": "What is the name of the primary insured party?",
    "context": "Insurance Information section. Identifies the policyholder, if different from the patient."
  },
  "CB31": {
    "name": "CB31",
    "type": "checkbox",
    "page": 2,
    "field_label": "Yes",
    "question": "Does the patient have other health coverage?",
    "context": "Insurance Information section. Determines if coordination of benefits is required due to multiple coverages."
  },
  "CB32": {
    "name": "CB32",
    "type": "checkbox",
    "page": 2,
    "field_label": "No",
    "question": "Does the patient not have other health coverage?",
    "context": "Insurance Information section. Determines if coordination of benefits is required due to multiple coverages."
  },
  "T33": {
    "name": "T33",
    "type": "text",
    "page": 2,
    "field_label": "If yes, provide ID#:",
    "question": "If the patient has other coverage, what is the ID number for that coverage?",
    "context": "Insurance Information section. Sub-question dependent on CB31 (Yes). Provides ID for secondary insurance."
  },
  "T34": {
    "name": "T34",
    "type": "text",
    "page": 2,
    "field_label": "Carrier Name:",
    "question": "What is the name of the patient's other insurance carrier?",
    "context": "Insurance Information section. Sub-question dependent on CB31 (Yes). Identifies the secondary insurance provider."
  },
  "T35": {
    "name": "T35",
    "type": "text",
    "page": 2,
    "field_label": "Insured:",
    "question": "What is the name of the primary insured party for the other coverage?",
    "context": "Insurance Information section. Sub-question dependent on CB31 (Yes). Identifies secondary policyholder."
  },
  "T42": {
    "name": "T42",
    "type": "text",
    "page": 2,
    "field_label": "First Name:",
    "question": "What is the prescriber's first name?",
    "context": "Prescriber Information section. Demographic data for the prescribing physician/provider."
  },
  "T43": {
    "name": "T43",
    "type": "text",
    "page": 2,
    "field_label": "Last Name:",
    "question": "What is the prescriber's last name?",
    "context": "Prescriber Information section. Demographic data for the prescribing physician/provider."
  },
  "CB44": {
    "name": "CB44",
    "type": "checkbox",
    "page": 2,
    "field_label": "M.D.",
    "question": "Is the prescriber an M.D. (Medical Doctor)?",
    "context": "Prescriber Information section. Primary question for the prescriber's medical degree/license type."
  },
  "CB45": {
    "name": "CB45",
    "type": "checkbox",
    "page": 2,
    "field_label": "D.O.",
    "question": "Is the prescriber a D.O. (Doctor of Osteopathic Medicine)?",
    "context": "Prescriber Information section. Primary question for the prescriber's medical degree/license type."
  },
  "CB46": {
    "name": "CB46",
    "type": "checkbox",
    "page": 2,
    "field_label": "N.P.",
    "question": "Is the prescriber an N.P. (Nurse Practitioner)?",
    "context": "Prescriber Information section. Primary question for the prescriber's medical degree/license type."
  },
  "CB47": {
    "name": "CB47",
    "type": "checkbox",
    "page": 2,
    "field_label": "P.A.",
    "question": "Is the prescriber a P.A. (Physician Assistant)?",
    "context": "Prescriber Information section. Primary question for the prescriber's medical degree/license type."
  },
  "T48": {
    "name": "T48",
    "type": "text",
    "page": 2,
    "field_label": "Address:",
    "question": "What is the prescriber's street address?",
    "context": "Prescriber Information section. Business address for the prescribing provider's practice."
  },
  "T49": {
    "name": "T49",
    "type": "text",
    "page": 2,
    "field_label": "City:",
    "question": "What is the prescriber's city?",
    "context": "Prescriber Information section. City for the prescribing provider's business address."
  },
  "T50": {
    "name": "T50",
    "type": "text",
    "page": 2,
    "field_label": "State:",
    "question": "What is the prescriber's state?",
    "context": "Prescriber Information section. State for the prescribing provider's business address."
  },
  "T51": {
    "name": "T51",
    "type": "text",
    "page": 2,
    "field_label": "ZIP:",
    "question": "What is the prescriber's ZIP code?",
    "context": "Prescriber Information section. ZIP code for the prescribing provider's business address."
  },
  "T52": {
    "name": "T52",
    "type": "text",
    "page": 2,
    "field_label": "Phone:",
    "question": "What is the prescriber's phone number?",
    "context": "Prescriber Information section. Primary contact number for the prescribing provider."
  },
  "T53": {
    "name": "T53",
    "type": "text",
    "page": 2,
    "field_label": "Fax:",
    "question": "What is the prescriber's fax number?",
    "context": "Prescriber Information section. Fax number for the prescribing provider's office."
  },
  "T54": {
    "name": "T54",
    "type": "text",
    "page": 2,
    "field_label": "St Lic #:",
    "question": "What is the prescriber's state license number?",
    "context": "Prescriber Information section. Professional license identifier for the prescribing provider."
  },
  "T55": {
    "name": "T55",
    "type": "text",
    "page": 2,
    "field_label": "NPI #:",
    "question": "What is the prescriber's NPI (National Provider Identifier) number?",
    "context": "Prescriber Information section. Unique identifier for healthcare providers used in HIPAA transactions."
  },
  "T56": {
    "name": "T56",
    "type": "text",
    "page": 2,
    "field_label": "DEA #:",
    "question": "What is the prescriber's DEA (Drug Enforcement Administration) number?",
    "context": "Prescriber Information section. Required for prescribing controlled substances."
  },
  "T57": {
    "name": "T57",
    "type": "text",
    "page": 2,
    "field_label": "UPIN:",
    "question": "What is the prescriber's UPIN (Unique Physician Identification Number)?",
    "context": "Prescriber Information section. Former Medicare identifier; may still be requested for provider identification."
  },
  "T58.0": {
    "name": "T58.0",
    "type": "text",
    "page": 2,
    "field_label": "Provider Email:",
    "question": "What is the prescriber's email address?",
    "context": "Prescriber Information section. Electronic contact information for the prescribing provider."
  },
  "T58.1": {
    "name": "T58.1",
    "type": "text",
    "page": 2,
    "field_label": "Office Contact Name:",
    "question": "What is the name of the office contact person for the prescriber?",
    "context": "Prescriber Information section. Name of a contact person at the prescriber's office."
  },
  "T59": {
    "name": "T59",
    "type": "text",
    "page": 2,
    "field_label": "Phone:",
    "question": "What is the office contact person's phone number?",
    "context": "Prescriber Information section. Phone number for the office contact person for general inquiries."
  },
  "Provider Admin CB.1": {
    "name": "Provider Admin CB.1",
    "type": "checkbox",
    "page": 2,
    "field_label": "Self-administered",
    "question": "Will the medication be self-administered by the patient?",
    "context": "Dispensing/Administration Information section. Indicates how the medication will be administered to the patient."
  },
  "Provider Admin CB.2": {
    "name": "Provider Admin CB.2",
    "type": "checkbox",
    "page": 2,
    "field_label": "Physician’s Office",
    "question": "Will the medication be administered at the physician's office?",
    "context": "Dispensing/Administration Information section. Specifies the location of medication administration."
  },
  "Provider Admin CB.3": {
    "name": "Provider Admin CB.3",
    "type": "checkbox",
    "page": 2,
    "field_label": "Home",
    "question": "Will the medication be administered at home?",
    "context": "Dispensing/Administration Information section. Specifies the location of medication administration."
  },
  "Provider Admin CB.4": {
    "name": "Provider Admin CB.4",
    "type": "checkbox",
    "page": 2,
    "field_label": "Outpatient Infusion Center",
    "question": "Will the medication be administered at an outpatient infusion center?",
    "context": "Dispensing/Administration Information section. Specifies the location of medication administration."
  },
  "Provider Admin T.5": {
    "name": "Provider Admin T.5",
    "type": "text",
    "page": 2,
    "field_label": "Name:",
    "question": "What is the name of the outpatient infusion center?",
    "context": "Dispensing/Administration Information section. Sub-question for specific outpatient infusion center details, if selected."
  },
  "Provider Admin CB.7": {
    "name": "Provider Admin CB.7",
    "type": "checkbox",
    "page": 2,
    "field_label": "Home Infusion Center",
    "question": "Will the medication be administered by a home infusion center?",
    "context": "Dispensing/Administration Information section. Specifies if medication administration occurs via home infusion."
  },
  "Provider Admin T.6": {
    "name": "Provider Admin T.6",
    "type": "text",
    "page": 2,
    "field_label": "Phone:",
    "question": "What is the phone number for the home infusion center?",
    "context": "Dispensing/Administration Information section. Sub-question for specific home infusion center details, if selected."
  },
  "Provider Admin T.8": {
    "name": "Provider Admin T.8",
    "type": "text",
    "page": 2,
    "field_label": "Agency Name:",
    "question": "What is the agency name for the home infusion center?",
    "context": "Dispensing/Administration Information section. Sub-question for specific home infusion center details, if selected."
  },
  "Provider Admin CB.10": {
    "name": "Provider Admin CB.10",
    "type": "checkbox",
    "page": 2,
    "field_label": "Administration code(s)",
    "question": "Will administration code(s) be provided for the medication?",
    "context": "Dispensing/Administration Information section. Indicates if CPT/HCPCS codes for administration will be included."
  },
  "Provider Admin T.9": {
    "name": "Provider Admin T.9",
    "type": "text",
    "page": 2,
    "field_label": "CPT:",
    "question": "What are the CPT administration code(s)?",
    "context": "Dispensing/Administration Information section. Sub-question for specific CPT codes for medication administration."
  },
  "Provider Admin T.11A": {
    "name": "Provider Admin T.11A",
    "type": "text",
    "page": 2,
    "field_label": "Address:",
    "question": "What is the address for the administering facility/provider?",
    "context": "Dispensing/Administration Information section. Address for the facility where medication is administered."
  },
  "Provider Admin T.13": {
    "name": "Provider Admin T.13",
    "type": "text",
    "page": 2,
    "field_label": "City:",
    "question": "What is the city for the administering facility/provider?",
    "context": "Dispensing/Administration Information section. City for the administering facility's address."
  },
  "Provider Admin T.14": {
    "name": "Provider Admin T.14",
    "type": "text",
    "page": 2,
    "field_label": "State:",
    "question": "What is the state for the administering facility/provider?",
    "context": "Dispensing/Administration Information section. State for the administering facility's address."
  },
  "Provider Admin T.15": {
    "name": "Provider Admin T.15",
    "type": "text",
    "page": 2,
    "field_label": "ZIP:",
    "question": "What is the ZIP code for the administering facility/provider?",
    "context": "Dispensing/Administration Information section. ZIP code for the administering facility's address."
  },
  "Provider Admin T.16": {
    "name": "Provider Admin T.16",
    "type": "text",
    "page": 2,
    "field_label": "Phone:",
    "question": "What is the phone number for the administering facility/provider?",
    "context": "Dispensing/Administration Information section. Phone number for the administering facility."
  },
  "Provider Admin T.17A": {
    "name": "Provider Admin T.17A",
    "type": "text",
    "page": 2,
    "field_label": "Fax:",
    "question": "What is the fax number for the administering facility/provider?",
    "context": "Dispensing/Administration Information section. Fax number for the administering facility."
  },
  "Provider Admin T.18": {
    "name": "Provider Admin T.18",
    "type": "text",
    "page": 2,
    "field_label": "TIN:",
    "question": "What is the Tax Identification Number (TIN) for the administering facility/provider?",
    "context": "Dispensing/Administration Information section. Financial identifier for the administering entity."
  },
  "Provider Admin T.19": {
    "name": "Provider Admin T.19",
    "type": "text",
    "page": 2,
    "field_label": "PIN:",
    "question": "What is the Provider Identification Number (PIN) for the administering facility/provider?",
    "context": "Dispensing/Administration Information section. Unique identifier assigned by the payer to the provider."
  },
  "Provider Admin T.20": {
    "name": "Provider Admin T.20",
    "type": "text",
    "page": 2,
    "field_label": "NPI:",
    "question": "What is the National Provider Identifier (NPI) for the administering facility/provider?",
    "context": "Dispensing/Administration Information section. Unique identifier for the healthcare provider/facility."
  },
  "Provider Admin CB.21": {
    "name": "Provider Admin CB.21",
    "type": "checkbox",
    "page": 2,
    "field_label": "Outpatient Dialysis Center",
    "question": "Will the medication be dispensed from an outpatient dialysis center?",
    "context": "Dispensing Provider Information section. Specifies source of dispensed medication for the patient."
  },
  "Provider Admin CB.22": {
    "name": "Provider Admin CB.22",
    "type": "checkbox",
    "page": 2,
    "field_label": "Physician’s Office",
    "question": "Will the medication be dispensed from a physician's office?",
    "context": "Dispensing Provider Information section. Specifies source of dispensed medication for the patient."
  },
  "Provider Admin CB.23.0.0": {
    "name": "Provider Admin CB.23.0.0",
    "type": "checkbox",
    "page": 2,
    "field_label": "Retail Pharmacy",
    "question": "Will the medication be dispensed from a retail pharmacy?",
    "context": "Dispensing Provider Information section. Specifies source of dispensed medication for the patient."
  },
  "Provider Admin CB.24.0.0": {
    "name": "Provider Admin CB.24.0.0",
    "type": "checkbox",
    "page": 2,
    "field_label": "Specialty Pharmacy",
    "question": "Will the medication be dispensed from a specialty pharmacy?",
    "context": "Dispensing Provider Information section. Specifies source of dispensed medication for the patient."
  },
  "Provider Admin CB.25": {
    "name": "Provider Admin CB.25",
    "type": "checkbox",
    "page": 2,
    "field_label": "Mail Order",
    "question": "Will the medication be dispensed via mail order?",
    "context": "Dispensing Provider Information section. Specifies source of dispensed medication for the patient."
  },
  "Provider Admin CB.26": {
    "name": "Provider Admin CB.26",
    "type": "checkbox",
    "page": 2,
    "field_label": "Other:",
    "question": "Will the medication be dispensed from another type of facility/provider not listed?",
    "context": "Dispensing Provider Information section. Catch-all option for other dispensing locations."
  },
  "Provider Admin T.27": {
    "name": "Provider Admin T.27",
    "type": "text",
    "page": 2,
    "field_label": "Other:",
    "question": "If 'Other' dispensing location is selected, please specify.",
    "context": "Dispensing Provider Information section. Sub-question dependent on 'Other' checkbox. Details alternate dispensing location."
  },
  "Provider Admin T.28": {
    "name": "Provider Admin T.28",
    "type": "text",
    "page": 2,
    "field_label": "Name:",
    "question": "What is the name of the dispensing provider/pharmacy?",
    "context": "Dispensing Provider Information section. Name of the entity dispensing the medication."
  },
  "Provider Admin T.29a": {
    "name": "Provider Admin T.29a",
    "type": "text",
    "page": 2,
    "field_label": "Address:",
    "question": "What is the street address of the dispensing provider/pharmacy?",
    "context": "Dispensing Provider Information section. Address of the entity dispensing the medication."
  },
  "Provider Admin T.30a": {
    "name": "Provider Admin T.30a",
    "type": "text",
    "page": 2,
    "field_label": "City:",
    "question": "What is the city of the dispensing provider/pharmacy?",
    "context": "Dispensing Provider Information section. City of the entity dispensing the medication."
  },
  "Provider Admin T.31": {
    "name": "Provider Admin T.31",
    "type": "text",
    "page": 2,
    "field_label": "State:",
    "question": "What is the state of the dispensing provider/pharmacy?",
    "context": "Dispensing Provider Information section. State of the entity dispensing the medication."
  },
  "Provider Admin T.32": {
    "name": "Provider Admin T.32",
    "type": "text",
    "page": 2,
    "field_label": "ZIP:",
    "question": "What is the ZIP code of the dispensing provider/pharmacy?",
    "context": "Dispensing Provider Information section. ZIP code of the entity dispensing the medication."
  },
  "Provider Admin T.33": {
    "name": "Provider Admin T.33",
    "type": "text",
    "page": 2,
    "field_label": "Phone:",
    "question": "What is the phone number for the dispensing provider/pharmacy?",
    "context": "Dispensing Provider Information section. Phone number for the dispensing entity."
  },
  "Provider Admin T.34": {
    "name": "Provider Admin T.34",
    "type": "text",
    "page": 2,
    "field_label": "Fax:",
    "question": "What is the fax number for the dispensing provider/pharmacy?",
    "context": "Dispensing Provider Information section. Fax number for the dispensing entity."
  },
  "Provider Admin T.35": {
    "name": "Provider Admin T.35",
    "type": "text",
    "page": 2,
    "field_label": "TIN:",
    "question": "What is the Tax Identification Number (TIN) for the dispensing provider/pharmacy?",
    "context": "Dispensing Provider Information section. Financial identifier for the dispensing entity."
  },
  "Provider Admin T.36": {
    "name": "Provider Admin T.36",
    "type": "text",
    "page": 2,
    "field_label": "PIN:",
    "question": "What is the Provider Identification Number (PIN) for the dispensing provider/pharmacy?",
    "context": "Dispensing Provider Information section. Unique identifier assigned by the payer to the dispensing entity."
  },
  "Provider Admin T.37": {
    "name": "Provider Admin T.37",
    "type": "text",
    "page": 2,
    "field_label": "NPI:",
    "question": "What is the National Provider Identifier (NPI) for the dispensing provider/pharmacy?",
    "context": "Dispensing Provider Information section. Unique identifier for the dispensing entity."
  },
  "CB60": {
    "name": "CB60",
    "type": "checkbox",
    "page": 2,
    "field_label": "Riabni (rituximab-arrx)",
    "question": "Is Riabni (rituximab-arrx) the requested product?",
    "context": "Product Information section. Identifies the specific Rituximab product requested for prior authorization."
  },
  "CB61": {
    "name": "CB61",
    "type": "checkbox",
    "page": 2,
    "field_label": "Rituxan (rituximab)",
    "question": "Is Rituxan (rituximab) the requested product?",
    "context": "Product Information section. Identifies the specific Rituximab product requested for prior authorization."
  },
  "CB62": {
    "name": "CB62",
    "type": "checkbox",
    "page": 2,
    "field_label": "Ruxience (rituximab-pvvr)",
    "question": "Is Ruxience (rituximab-pvvr) the requested product?",
    "context": "Product Information section. Identifies the specific Rituximab biosimilar requested for prior authorization."
  },
  "CB63": {
    "name": "CB63",
    "type": "checkbox",
    "page": 2,
    "field_label": "Truxima (rituximab-abbs)",
    "question": "Is Truxima (rituximab-abbs) the requested product?",
    "context": "Product Information section. Identifies the specific Rituximab biosimilar requested for prior authorization."
  },
  "T64": {
    "name": "T64",
    "type": "text",
    "page": 2,
    "field_label": "Dose:",
    "question": "What is the requested dose of the medication?",
    "context": "Product Information section. Specifies the quantity of medication to be administered per dose."
  },
  "T65": {
    "name": "T65",
    "type": "text",
    "page": 2,
    "field_label": "Directions for Use:",
    "question": "What are the directions for using the requested medication?",
    "context": "Product Information section. Provides instructions for medication administration, including frequency and route."
  },
  "T66": {
    "name": "T66",
    "type": "text",
    "page": 2,
    "field_label": "HCPCS Code:",
    "question": "What is the HCPCS (Healthcare Common Procedure Coding System) code for the requested product/service?",
    "context": "Product Information section. Standardized code for medical procedures, services, or supplies."
  },
  "T67": {
    "name": "T67",
    "type": "text",
    "page": 2,
    "field_label": "Primary ICD Code:",
    "question": "What is the patient's primary ICD (International Classification of Diseases) code for their diagnosis?",
    "context": "Diagnosis Information section. Primary medical diagnosis code supporting the precertification request."
  },
  "CB68": {
    "name": "CB68",
    "type": "checkbox",
    "page": 2,
    "field_label": "Other ICD Code:",
    "question": "Is there another ICD code applicable to the patient's diagnosis?",
    "context": "Diagnosis Information section. Indicates if additional diagnostic codes will be provided for clinical context."
  },
  "T69": {
    "name": "T69",
    "type": "text",
    "page": 2,
    "field_label": "Other ICD Code:",
    "question": "What is the patient's other applicable ICD code?",
    "context": "Diagnosis Information section. Sub-question dependent on CB68. Provides secondary diagnosis codes."
  },
  "CB70": {
    "name": "CB70",
    "type": "checkbox",
    "page": 2,
    "field_label": "Yes",
    "question": "Has the patient had prior therapy with the requested product within the last 365 days?",
    "context": "Clinical Information (Initiation) section. Inquires about recent use of the requested drug for patient history."
  },
  "CB71": {
    "name": "CB71",
    "type": "checkbox",
    "page": 2,
    "field_label": "No",
    "question": "Has the patient not had prior therapy with the requested product within the last 365 days?",
    "context": "Clinical Information (Initiation) section. Inquires about recent use of the requested drug for patient history."
  },
  "CB72": {
    "name": "CB72",
    "type": "checkbox",
    "page": 2,
    "field_label": "No",
    "question": "Has the patient not had a trial and failure of any of the listed rituximab biosimilars?",
    "context": "Clinical Information (Initiation) section. Evaluates if patient has tried preferred biosimilars before requesting non-preferred."
  },
  "CB73": {
    "name": "CB73",
    "type": "checkbox",
    "page": 2,
    "field_label": "Ruxience (rituximab-pvvr)",
    "question": "Has the patient had a trial and failure of Ruxience (rituximab-pvvr)?",
    "context": "Clinical Information (Initiation) section. Sub-question if patient failed specific preferred rituximab biosimilar."
  },
  "CB74": {
    "name": "CB74",
    "type": "checkbox",
    "page": 2,
    "field_label": "Truxima (rituximab-abbs)",
    "question": "Has the patient had a trial and failure of Truxima (rituximab-abbs)?",
    "context": "Clinical Information (Initiation) section. Sub-question if patient failed specific preferred rituximab biosimilar."
  },
  "T75": {
    "name": "T75",
    "type": "text",
    "page": 2,
    "field_label": "When was the member’s trial and failure of the preferred drug?",
    "question": "When did the member's trial and failure of the preferred drug occur?",
    "context": "Clinical Information (Initiation) section. Date of unsuccessful treatment with a preferred biosimilar."
  },
  "T76": {
    "name": "T76",
    "type": "text",
    "page": 2,
    "field_label": "Please describe the nature of the failure of the preferred drug",
    "question": "Please describe the nature of the failure of the preferred drug for the patient.",
    "context": "Clinical Information (Initiation) section. Details clinical reason for prior preferred therapy failure (e.g., lack of efficacy)."
  },
  "CB77": {
    "name": "CB77",
    "type": "checkbox",
    "page": 2,
    "field_label": "No",
    "question": "Has the patient not had an adverse reaction to any of the listed rituximab biosimilars?",
    "context": "Clinical Information (Initiation) section. Evaluates if patient had adverse reactions to preferred biosimilars."
  },
  "CB78": {
    "name": "CB78",
    "type": "checkbox",
    "page": 2,
    "field_label": "Ruxience (rituximab-pvvr)",
    "question": "Has the patient had an adverse reaction to Ruxience (rituximab-pvvr)?",
    "context": "Clinical Information (Initiation) section. Sub-question if patient experienced adverse reaction to specific preferred biosimilar."
  },
  "CB79": {
    "name": "CB79",
    "type": "checkbox",
    "page": 2,
    "field_label": "Truxima (rituximab-abbs)",
    "question": "Has the patient had an adverse reaction to Truxima (rituximab-abbs)?",
    "context": "Clinical Information (Initiation) section. Sub-question if patient experienced adverse reaction to specific preferred biosimilar."
  },
  "T80": {
    "name": "T80",
    "type": "text",
    "page": 2,
    "field_label": "When was the member’s adverse reaction to the preferred drug?",
    "question": "When did the member's adverse reaction to the preferred drug occur?",
    "context": "Clinical Information (Initiation) section. Date of adverse event with a preferred biosimilar, if applicable."
  },
  "T81": {
    "name": "T81",
    "type": "text",
    "page": 2,
    "field_label": "Please describe the nature of the adverse reaction to the preferred drug",
    "question": "Please describe the nature of the adverse reaction experienced by the patient to the preferred drug.",
    "context": "Clinical Information (Initiation) section. Details clinical reason for adverse reaction to previous preferred therapy."
  },
  "T84": {
    "name": "T84",
    "type": "text",
    "page": 2,
    "field_label": "Please explain if there are any contraindications or other medical reason(s) that the patient cannot use any of the following preferred biosimilar products when indicated for the patient’s diagnosis?",
    "question": "Are there any contraindications or medical reasons preventing the patient from using the preferred biosimilar products? If so, please explain.",
    "context": "Clinical Information (Initiation) section. Justification for not using preferred biosimilars due to medical necessity."
  },
  "CB82": {
    "name": "CB82",
    "type": "checkbox",
    "page": 2,
    "field_label": "Ruxience (rituximab-pvvr)",
    "question": "Is Ruxience (rituximab-pvvr) contraindicated or medically unsuitable for the patient?",
    "context": "Clinical Information (Initiation) section. Sub-question for specific preferred biosimilar contraindication details."
  },
  "CB83": {
    "name": "CB83",
    "type": "checkbox",
    "page": 2,
    "field_label": "Truxima (rituximab-abbs)",
    "question": "Is Truxima (rituximab-abbs) contraindicated or medically unsuitable for the patient?",
    "context": "Clinical Information (Initiation) section. Sub-question for specific preferred biosimilar contraindication details."
  },
  "CB86": {
    "name": "CB86",
    "type": "checkbox",
    "page": 3,
    "field_label": "Inflectra (infliximab-dyyb)",
    "question": "Has the patient had a trial and failure of Inflectra (infliximab-dyyb)?",
    "context": "Clinical history: Indicates if a trial and failure of Inflectra, a preferred biosimilar, occurred for this initiation request."
  },
  "CB87": {
    "name": "CB87",
    "type": "checkbox",
    "page": 3,
    "field_label": "Renflexis (infliximab-abda)",
    "question": "Has the patient had a trial and failure of Renflexis (infliximab-abda)?",
    "context": "Clinical history: Indicates if a trial and failure of Renflexis, a preferred biosimilar, occurred for this initiation request."
  },
  "CB88": {
    "name": "CB88",
    "type": "checkbox",
    "page": 3,
    "field_label": "Simponi Aria (golimumab)",
    "question": "Has the patient had a trial and failure of Simponi Aria (golimumab)?",
    "context": "Clinical history: Indicates if a trial and failure of Simponi Aria, a preferred biologic, occurred for this initiation request."
  },
  "T89": {
    "name": "T89",
    "type": "text",
    "page": 3,
    "field_label": "When was the member’s trial and failure of the preferred drug?",
    "question": "When did the patient's trial and failure of the preferred drug occur?",
    "context": "Clinical history: Specifies the date of trial and failure, important for assessing recency and treatment progression. Dependent on prior checkbox selection."
  },
  "T90": {
    "name": "T90",
    "type": "text",
    "page": 3,
    "field_label": "Please describe the nature of the failure of the preferred drug",
    "question": "Describe the nature of the patient's failure with the preferred drug.",
    "context": "Clinical history: Details why the preferred drug failed (e.g., lack of efficacy, progression). Dependent on prior checkbox selection."
  },
  "CB85": {
    "name": "CB85",
    "type": "checkbox",
    "page": 3,
    "field_label": "No",
    "question": "Has the patient NOT had a trial and failure of any specified rituximab biosimilars?",
    "context": "Clinical history: Indicates if the patient has not undergone trial and failure of the listed preferred drugs."
  },
  "CB92": {
    "name": "CB92",
    "type": "checkbox",
    "page": 3,
    "field_label": "Inflectra (infliximab-dyyb)",
    "question": "Has the patient had an adverse reaction to Inflectra (infliximab-dyyb)?",
    "context": "Clinical history: Indicates if the patient experienced an adverse reaction to Inflectra, a preferred biosimilar."
  },
  "CB93": {
    "name": "CB93",
    "type": "checkbox",
    "page": 3,
    "field_label": "Renflexis (infliximab-abda)",
    "question": "Has the patient had an adverse reaction to Renflexis (infliximab-abda)?",
    "context": "Clinical history: Indicates if the patient experienced an adverse reaction to Renflexis, a preferred biosimilar."
  },
  "CB94": {
    "name": "CB94",
    "type": "checkbox",
    "page": 3,
    "field_label": "Simponi Aria (golimumab)",
    "question": "Has the patient had an adverse reaction to Simponi Aria (golimumab)?",
    "context": "Clinical history: Indicates if the patient experienced an adverse reaction to Simponi Aria, a preferred biologic."
  },
  "T95": {
    "name": "T95",
    "type": "text",
    "page": 3,
    "field_label": "When was the member’s adverse reaction to the preferred drug?",
    "question": "When did the patient's adverse reaction to the preferred drug occur?",
    "context": "Clinical history: Specifies the date of the adverse reaction, crucial for causality and treatment plan adjustments. Dependent on prior checkbox selection."
  },
  "T96a": {
    "name": "T96a",
    "type": "text",
    "page": 3,
    "field_label": "Please describe the nature of the adverse reaction to the preferred drug",
    "question": "Describe the nature of the patient's adverse reaction to the preferred drug.",
    "context": "Clinical history: Details the type and severity of the adverse reaction to the preferred drug. Dependent on prior checkbox selection."
  },
  "CB91": {
    "name": "CB91",
    "type": "checkbox",
    "page": 3,
    "field_label": "No",
    "question": "Has the patient NOT had an adverse reaction to any specified rituximab biosimilars?",
    "context": "Clinical history: Indicates if the patient has not experienced adverse reactions to the listed preferred drugs."
  },
  "CB98a": {
    "name": "CB98a",
    "type": "checkbox",
    "page": 3,
    "field_label": "Enbrel (etanercept)",
    "question": "Has the patient had a trial and failure of Enbrel (etanercept)?",
    "context": "Clinical history: Indicates if a trial and failure of Enbrel, a preferred biologic, occurred for this initiation request."
  },
  "CB99a": {
    "name": "CB99a",
    "type": "checkbox",
    "page": 3,
    "field_label": "Humira (adalimumab)",
    "question": "Has the patient had a trial and failure of Humira (adalimumab)?",
    "context": "Clinical history: Indicates if a trial and failure of Humira, a preferred biologic, occurred for this initiation request."
  },
  "CB100a": {
    "name": "CB100a",
    "type": "checkbox",
    "page": 3,
    "field_label": "Idacio (adalimumab-aacf)",
    "question": "Has the patient had a trial and failure of Idacio (adalimumab-aacf)?",
    "context": "Clinical history: Indicates if a trial and failure of Idacio, a preferred biosimilar, occurred for this initiation request."
  },
  "CB101a": {
    "name": "CB101a",
    "type": "checkbox",
    "page": 3,
    "field_label": "Rinvoq (upadacitinib)",
    "question": "Has the patient had a trial and failure of Rinvoq (upadacitinib)?",
    "context": "Clinical history: Indicates if a trial and failure of Rinvoq, a preferred JAK inhibitor, occurred for this initiation request."
  },
  "CB102a": {
    "name": "CB102a",
    "type": "checkbox",
    "page": 3,
    "field_label": "Tyenne SC (tocilizumab-aazg)",
    "question": "Has the patient had a trial and failure of Tyenne SC (tocilizumab-aazg)?",
    "context": "Clinical history: Indicates if a trial and failure of Tyenne SC, a preferred biosimilar, occurred for this initiation request."
  },
  "CB103a": {
    "name": "CB103a",
    "type": "checkbox",
    "page": 3,
    "field_label": "Xeljanz/Xeljanz XR (tofacitinib)",
    "question": "Has the patient had a trial and failure of Xeljanz/Xeljanz XR (tofacitinib)?",
    "context": "Clinical history: Indicates if a trial and failure of Xeljanz/Xeljanz XR, a preferred JAK inhibitor, occurred for this initiation request."
  },
  "T104": {
    "name": "T104",
    "type": "text",
    "page": 3,
    "field_label": "When was the member’s trial and failure of the preferred drug?",
    "question": "When did the patient's trial and failure of the preferred drug occur?",
    "context": "Clinical history: Specifies the date of trial and failure, important for assessing recency and treatment progression. Dependent on prior checkbox selection."
  },
  "T105": {
    "name": "T105",
    "type": "text",
    "page": 3,
    "field_label": "Please describe the nature of the failure of the preferred drug",
    "question": "Describe the nature of the patient's failure with the preferred drug.",
    "context": "Clinical history: Details why the preferred drug failed (e.g., lack of efficacy, progression). Dependent on prior checkbox selection."
  },
  "CB97": {
    "name": "CB97",
    "type": "checkbox",
    "page": 3,
    "field_label": "No",
    "question": "Has the patient NOT had a trial and failure of any specified preferred products?",
    "context": "Clinical history: Indicates if the patient has not undergone trial and failure of the listed preferred drugs."
  },
  "CB107z": {
    "name": "CB107z",
    "type": "checkbox",
    "page": 3,
    "field_label": "Enbrel (etanercept)",
    "question": "Has the patient had an adverse reaction to Enbrel (etanercept)?",
    "context": "Clinical history: Indicates if the patient experienced an adverse reaction to Enbrel, a preferred biologic."
  },
  "CB108z": {
    "name": "CB108z",
    "type": "checkbox",
    "page": 3,
    "field_label": "Humira (adalimumab)",
    "question": "Has the patient had an adverse reaction to Humira (adalimumab)?",
    "context": "Clinical history: Indicates if the patient experienced an adverse reaction to Humira, a preferred biologic."
  },
  "CB109z": {
    "name": "CB109z",
    "type": "checkbox",
    "page": 3,
    "field_label": "Idacio (adalimumab-aacf)",
    "question": "Has the patient had an adverse reaction to Idacio (adalimumab-aacf)?",
    "context": "Clinical history: Indicates if the patient experienced an adverse reaction to Idacio, a preferred biosimilar."
  },
  "CB110z": {
    "name": "CB110z",
    "type": "checkbox",
    "page": 3,
    "field_label": "Rinvoq (upadacitinib)",
    "question": "Has the patient had an adverse reaction to Rinvoq (upadacitinib)?",
    "context": "Clinical history: Indicates if the patient experienced an adverse reaction to Rinvoq, a preferred JAK inhibitor."
  },
  "CB111z": {
    "name": "CB111z",
    "type": "checkbox",
    "page": 3,
    "field_label": "Tyenne SC (tocilizumab-aazg)",
    "question": "Has the patient had an adverse reaction to Tyenne SC (tocilizumab-aazg)?",
    "context": "Clinical history: Indicates if the patient experienced an adverse reaction to Tyenne SC, a preferred biosimilar."
  },
  "CB112z": {
    "name": "CB112z",
    "type": "checkbox",
    "page": 3,
    "field_label": "Xeljanz/Xeljanz XR (tofacitinib)",
    "question": "Has the patient had an adverse reaction to Xeljanz/Xeljanz XR (tofacitinib)?",
    "context": "Clinical history: Indicates if the patient experienced an adverse reaction to Xeljanz/Xeljanz XR, a preferred JAK inhibitor."
  },
  "T113": {
    "name": "T113",
    "type": "text",
    "page": 3,
    "field_label": "When was the member’s adverse reaction to the preferred drug?",
    "question": "When did the patient's adverse reaction to the preferred drug occur?",
    "context": "Clinical history: Specifies the date of the adverse reaction, crucial for causality and treatment plan adjustments. Dependent on prior checkbox selection."
  },
  "T114": {
    "name": "T114",
    "type": "text",
    "page": 3,
    "field_label": "Please describe the nature of the adverse reaction to the preferred drug",
    "question": "Describe the nature of the patient's adverse reaction to the preferred drug.",
    "context": "Clinical history: Details the type and severity of the adverse reaction to the preferred drug. Dependent on prior checkbox selection."
  },
  "CB106z": {
    "name": "CB106z",
    "type": "checkbox",
    "page": 3,
    "field_label": "No",
    "question": "Has the patient NOT had an adverse reaction to any specified preferred products?",
    "context": "Clinical history: Indicates if the patient has not experienced adverse reactions to the listed preferred drugs."
  },
  "T118": {
    "name": "T118",
    "type": "text",
    "page": 3,
    "field_label": "Please explain if there are any contraindications or other medical reason(s) that the patient cannot use any of the following preferred products when indicated for the patient’s diagnosis?",
    "question": "Are there medical reasons or contraindications preventing the patient from using the preferred products for their diagnosis?",
    "context": "Clinical justification: Provides medical reasons for not using preferred rituximab biosimilars (Ruxience/Truxima) due to contraindications or other factors."
  },
  "CB115z": {
    "name": "CB115z",
    "type": "checkbox",
    "page": 3,
    "field_label": "Inflectra (infliximab-dyyb)",
    "question": "Is Inflectra (infliximab-dyyb) contraindicated or medically unsuitable for the patient?",
    "context": "Clinical justification: Indicates if Inflectra, a preferred biosimilar, is medically unsuitable or contraindicated for the patient's diagnosis."
  },
  "CB116z": {
    "name": "CB116z",
    "type": "checkbox",
    "page": 3,
    "field_label": "Renflexis (infliximab-abda)",
    "question": "Is Renflexis (infliximab-abda) contraindicated or medically unsuitable for the patient?",
    "context": "Clinical justification: Indicates if Renflexis, a preferred biosimilar, is medically unsuitable or contraindicated for the patient's diagnosis."
  },
  "CB117z": {
    "name": "CB117z",
    "type": "checkbox",
    "page": 3,
    "field_label": "Simponi Aria (golimumab)",
    "question": "Is Simponi Aria (golimumab) contraindicated or medically unsuitable for the patient?",
    "context": "Clinical justification: Indicates if Simponi Aria, a preferred biologic, is medically unsuitable or contraindicated for the patient's diagnosis."
  },
  "T125": {
    "name": "T125",
    "type": "text",
    "page": 3,
    "field_label": "Please explain if there are contraindications or any other medical reason(s) that the patient cannot use any of the following preferred products when indicated for the patient’s diagnosis?",
    "question": "Are there medical reasons or contraindications preventing the patient from using the listed preferred products for their diagnosis?",
    "context": "Clinical justification: Provides medical reasons for not using other preferred biologics/JAK inhibitors due to contraindications or other factors."
  },
  "CB119z": {
    "name": "CB119z",
    "type": "checkbox",
    "page": 3,
    "field_label": "Enbrel (etanercept)",
    "question": "Is Enbrel (etanercept) contraindicated or medically unsuitable for the patient?",
    "context": "Clinical justification: Indicates if Enbrel, a preferred biologic, is medically unsuitable or contraindicated for the patient's diagnosis."
  },
  "CB120z": {
    "name": "CB120z",
    "type": "checkbox",
    "page": 3,
    "field_label": "Humira (adalimumab)",
    "question": "Is Humira (adalimumab) contraindicated or medically unsuitable for the patient?",
    "context": "Clinical justification: Indicates if Humira, a preferred biologic, is medically unsuitable or contraindicated for the patient's diagnosis."
  },
  "CB121z": {
    "name": "CB121z",
    "type": "checkbox",
    "page": 3,
    "field_label": "Idacio (adalimumab-aacf)",
    "question": "Is Idacio (adalimumab-aacf) contraindicated or medically unsuitable for the patient?",
    "context": "Clinical justification: Indicates if Idacio, a preferred biosimilar, is medically unsuitable or contraindicated for the patient's diagnosis."
  },
  "CB122z": {
    "name": "CB122z",
    "type": "checkbox",
    "page": 3,
    "field_label": "Rinvoq (upadacitinib)",
    "question": "Is Rinvoq (upadacitinib) contraindicated or medically unsuitable for the patient?",
    "context": "Clinical justification: Indicates if Rinvoq, a preferred JAK inhibitor, is medically unsuitable or contraindicated for the patient's diagnosis."
  },
  "CB123z": {
    "name": "CB123z",
    "type": "checkbox",
    "page": 3,
    "field_label": "Tyenne SC (tocilizumab-aazg)",
    "question": "Is Tyenne SC (tocilizumab-aazg) contraindicated or medically unsuitable for the patient?",
    "context": "Clinical justification: Indicates if Tyenne SC, a preferred biosimilar, is medically unsuitable or contraindicated for the patient's diagnosis."
  },
  "CB124z": {
    "name": "CB124z",
    "type": "checkbox",
    "page": 3,
    "field_label": "Xeljanz/Xeljanz XR (tofacitinib)",
    "question": "Is Xeljanz/Xeljanz XR (tofacitinib) contraindicated or medically unsuitable for the patient?",
    "context": "Clinical justification: Indicates if Xeljanz/Xeljanz XR, a preferred JAK inhibitor, is medically unsuitable or contraindicated for the patient's diagnosis."
  },
  "CB96.4.0": {
    "name": "CB96.4.0",
    "type": "checkbox",
    "page": 3,
    "field_label": "Yes",
    "question": "Will Rituxan (rituximab) be used concomitantly with other specified DMARDs?",
    "context": "Treatment plan: Specifies if Rituxan will be co-administered with other immunosuppressants, crucial for drug interaction assessment."
  },
  "CB98": {
    "name": "CB98",
    "type": "checkbox",
    "page": 3,
    "field_label": "No",
    "question": "Will Rituxan (rituximab) NOT be used concomitantly with other specified DMARDs?",
    "context": "Treatment plan: Specifies if Rituxan will not be co-administered with other immunosuppressants, crucial for drug interaction assessment."
  },
  "CB99.0": {
    "name": "CB99.0",
    "type": "checkbox",
    "page": 3,
    "field_label": "Yes",
    "question": "Does the patient have a documented diagnosis of Philadelphia chromosome-negative acute lymphoid leukemia (ALL)?",
    "context": "Diagnosis verification: Confirms a specific ALL subtype, critical for medical necessity of Rituxan therapy."
  },
  "CB100.0": {
    "name": "CB100.0",
    "type": "checkbox",
    "page": 3,
    "field_label": "No",
    "question": "Does the patient NOT have a documented diagnosis of Philadelphia chromosome-negative acute lymphoid leukemia (ALL)?",
    "context": "Diagnosis verification: Confirms absence of a specific ALL subtype, critical for medical necessity of Rituxan therapy."
  },
  "CB101.0": {
    "name": "CB101.0",
    "type": "checkbox",
    "page": 3,
    "field_label": "Yes",
    "question": "Is Rituxan (rituximab) being used as induction/consolidation therapy for ALL?",
    "context": "Treatment indication: Specifies the phase of ALL treatment, indicating Rituxan's role in the regimen."
  },
  "CB102.0": {
    "name": "CB102.0",
    "type": "checkbox",
    "page": 3,
    "field_label": "No",
    "question": "Is Rituxan (rituximab) NOT being used as induction/consolidation therapy for ALL?",
    "context": "Treatment indication: Specifies the phase of ALL treatment, indicating Rituxan's role in the regimen."
  },
  "CB103": {
    "name": "CB103",
    "type": "checkbox",
    "page": 3,
    "field_label": "Yes",
    "question": "Does the patient have a documented diagnosis of refractory autoimmune hemolytic anemia?",
    "context": "Diagnosis verification: Confirms a diagnosis of refractory AIHA, a specific indication for Rituxan."
  },
  "CB104": {
    "name": "CB104",
    "type": "checkbox",
    "page": 3,
    "field_label": "No",
    "question": "Does the patient NOT have a documented diagnosis of refractory autoimmune hemolytic anemia?",
    "context": "Diagnosis verification: Confirms absence of a diagnosis of refractory AIHA, a specific indication for Rituxan."
  },
  "CB104a": {
    "name": "CB104a",
    "type": "checkbox",
    "page": 3,
    "field_label": "Wegener granulomatosis",
    "question": "Does the patient have Wegener granulomatosis (now Granulomatosis with Polyangiitis)?",
    "context": "Specific diagnosis: Indicates a subtype of ANCA-associated vasculitides, crucial for treatment protocol adherence."
  },
  "CB104b": {
    "name": "CB104b",
    "type": "checkbox",
    "page": 3,
    "field_label": "Churg-Strauss syndrome",
    "question": "Does the patient have Churg-Strauss syndrome (now Eosinophilic Granulomatosis with Polyangiitis)?",
    "context": "Specific diagnosis: Indicates a subtype of ANCA-associated vasculitides, crucial for treatment protocol adherence."
  },
  "CB104c": {
    "name": "CB104c",
    "type": "checkbox",
    "page": 3,
    "field_label": "microscopic polyangiitis",
    "question": "Does the patient have microscopic polyangiitis?",
    "context": "Specific diagnosis: Indicates a subtype of ANCA-associated vasculitides, crucial for treatment protocol adherence."
  },
  "CB104d": {
    "name": "CB104d",
    "type": "checkbox",
    "page": 3,
    "field_label": "pauci-immune glomerulonephritis",
    "question": "Does the patient have pauci-immune glomerulonephritis?",
    "context": "Specific diagnosis: Indicates a subtype of ANCA-associated vasculitides, crucial for treatment protocol adherence."
  },
  "CB105": {
    "name": "CB105",
    "type": "checkbox",
    "page": 3,
    "field_label": "Yes",
    "question": "Will Rituxan (rituximab) be given in conjunction with glucocorticoids?",
    "context": "Treatment plan: Specifies if Rituxan will be co-administered with glucocorticoids, crucial for combination therapy assessment."
  },
  "CB106": {
    "name": "CB106",
    "type": "checkbox",
    "page": 3,
    "field_label": "No",
    "question": "Will Rituxan (rituximab) NOT be given in conjunction with glucocorticoids?",
    "context": "Treatment plan: Specifies if Rituxan will not be co-administered with glucocorticoids, crucial for combination therapy assessment."
  },
  "CB106a": {
    "name": "CB106a",
    "type": "checkbox",
    "page": 3,
    "field_label": "Yes",
    "question": "Does the patient have a documented diagnosis of corticosteroid-refractory autoimmune blistering disease?",
    "context": "Diagnosis verification: Confirms diagnosis of corticosteroid-refractory autoimmune blistering disease, a specific indication for Rituxan."
  },
  "CB107": {
    "name": "CB107",
    "type": "checkbox",
    "page": 3,
    "field_label": "pemphigus vulgaris",
    "question": "Does the patient have pemphigus vulgaris?",
    "context": "Specific diagnosis: Identifies the subtype of autoimmune blistering disease for treatment validation."
  },
  "CB108": {
    "name": "CB108",
    "type": "checkbox",
    "page": 3,
    "field_label": "pemphigus folliaceus",
    "question": "Does the patient have pemphigus folliaceus?",
    "context": "Specific diagnosis: Identifies the subtype of autoimmune blistering disease for treatment validation."
  },
  "CB109": {
    "name": "CB109",
    "type": "checkbox",
    "page": 3,
    "field_label": "bullous pemphigoid",
    "question": "Does the patient have bullous pemphigoid?",
    "context": "Specific diagnosis: Identifies the subtype of autoimmune blistering disease for treatment validation."
  },
  "CB110": {
    "name": "CB110",
    "type": "checkbox",
    "page": 3,
    "field_label": "cicatricial pemphigoid",
    "question": "Does the patient have cicatricial pemphigoid?",
    "context": "Specific diagnosis: Identifies the subtype of autoimmune blistering disease for treatment validation."
  },
  "CB111": {
    "name": "CB111",
    "type": "checkbox",
    "page": 3,
    "field_label": "epidermolysis bullosa acquisita",
    "question": "Does the patient have epidermolysis bullosa acquisita?",
    "context": "Specific diagnosis: Identifies the subtype of autoimmune blistering disease for treatment validation."
  },
  "CB112": {
    "name": "CB112",
    "type": "checkbox",
    "page": 3,
    "field_label": "paraneoplastic pemphigus",
    "question": "Does the patient have paraneoplastic pemphigus?",
    "context": "Specific diagnosis: Identifies the subtype of autoimmune blistering disease for treatment validation."
  },
  "CB113": {
    "name": "CB113",
    "type": "checkbox",
    "page": 3,
    "field_label": "None of the above",
    "question": "Does the patient have none of the listed autoimmune blistering diseases?",
    "context": "Specific diagnosis: Indicates that none of the specific autoimmune blistering disease subtypes apply."
  },
  "CB106b": {
    "name": "CB106b",
    "type": "checkbox",
    "page": 3,
    "field_label": "No",
    "question": "Does the patient NOT have a documented diagnosis of corticosteroid-refractory autoimmune blistering disease?",
    "context": "Diagnosis verification: Confirms absence of diagnosis of corticosteroid-refractory autoimmune blistering disease."
  },
  "CB114": {
    "name": "CB114",
    "type": "checkbox",
    "page": 3,
    "field_label": "AIDS-related B-cell lymphoma",
    "question": "Does the patient have AIDS-related B-cell lymphoma?",
    "context": "Specific diagnosis: Identifies the subtype of B-cell lymphoma, relevant for treatment indication."
  },
  "CB115": {
    "name": "CB115",
    "type": "checkbox",
    "page": 3,
    "field_label": "Burkitt lymphoma",
    "question": "Does the patient have Burkitt lymphoma?",
    "context": "Specific diagnosis: Identifies the subtype of B-cell lymphoma, relevant for treatment indication."
  },
  "CB116": {
    "name": "CB116",
    "type": "checkbox",
    "page": 3,
    "field_label": "Diffuse large B-cell lymphoma",
    "question": "Does the patient have Diffuse large B-cell lymphoma?",
    "context": "Specific diagnosis: Identifies the subtype of B-cell lymphoma, relevant for treatment indication."
  },
  "CB117": {
    "name": "CB117",
    "type": "checkbox",
    "page": 3,
    "field_label": "Follicular lymphoma",
    "question": "Does the patient have Follicular lymphoma?",
    "context": "Specific diagnosis: Identifies the subtype of B-cell lymphoma, relevant for treatment indication."
  },
  "CB118": {
    "name": "CB118",
    "type": "checkbox",
    "page": 3,
    "field_label": "Gastric MALT lymphoma",
    "question": "Does the patient have Gastric MALT lymphoma?",
    "context": "Specific diagnosis: Identifies the subtype of B-cell lymphoma, relevant for treatment indication."
  },
  "CB119": {
    "name": "CB119",
    "type": "checkbox",
    "page": 3,
    "field_label": "High-grade B-Cell lymphoma",
    "question": "Does the patient have High-grade B-Cell lymphoma?",
    "context": "Specific diagnosis: Identifies the subtype of B-cell lymphoma, relevant for treatment indication."
  },
  "CB120": {
    "name": "CB120",
    "type": "checkbox",
    "page": 3,
    "field_label": "Mantle cell lymphoma",
    "question": "Does the patient have Mantle cell lymphoma?",
    "context": "Specific diagnosis: Identifies the subtype of B-cell lymphoma, relevant for treatment indication."
  },
  "CB121": {
    "name": "CB121",
    "type": "checkbox",
    "page": 3,
    "field_label": "Nodal marginal zone lymphoma",
    "question": "Does the patient have Nodal marginal zone lymphoma?",
    "context": "Specific diagnosis: Identifies the subtype of B-cell lymphoma, relevant for treatment indication."
  },
  "CB122": {
    "name": "CB122",
    "type": "checkbox",
    "page": 3,
    "field_label": "Nongastric MALT lymphoma",
    "question": "Does the patient have Nongastric MALT lymphoma?",
    "context": "Specific diagnosis: Identifies the subtype of B-cell lymphoma, relevant for treatment indication."
  },
  "CB123": {
    "name": "CB123",
    "type": "checkbox",
    "page": 3,
    "field_label": "Primary cutaneous B-cell lymphomas",
    "question": "Does the patient have Primary cutaneous B-cell lymphomas?",
    "context": "Specific diagnosis: Identifies the subtype of B-cell lymphoma, relevant for treatment indication."
  },
  "CB124": {
    "name": "CB124",
    "type": "checkbox",
    "page": 3,
    "field_label": "Splenic marginal zone lymphoma",
    "question": "Does the patient have Splenic marginal zone lymphoma?",
    "context": "Specific diagnosis: Identifies the subtype of B-cell lymphoma, relevant for treatment indication."
  },
  "CB125": {
    "name": "CB125",
    "type": "checkbox",
    "page": 3,
    "field_label": "Other:",
    "question": "Does the patient have another type of B-cell lymphoma not listed?",
    "context": "Specific diagnosis: Allows for specification of other B-cell lymphoma subtypes not explicitly listed."
  },
  "T126": {
    "name": "T126",
    "type": "text",
    "page": 3,
    "field_label": "Other:",
    "question": "Please specify the 'Other' B-cell lymphoma type.",
    "context": "Specific diagnosis: Text field to describe any other B-cell lymphoma subtype if 'Other' is selected."
  },
  "CB127": {
    "name": "CB127",
    "type": "checkbox",
    "page": 4,
    "field_label": "Yes",
    "question": "Does the patient have a documented diagnosis of multicentric Castleman's disease?",
    "context": "Clinical criteria for Castleman's disease diagnosis, required for treatment approval."
  },
  "CB128": {
    "name": "CB128",
    "type": "checkbox",
    "page": 4,
    "field_label": "No",
    "question": "Does the patient not have a documented diagnosis of multicentric Castleman's disease?",
    "context": "Indicates absence of Castleman's disease, affecting treatment eligibility."
  },
  "CB129": {
    "name": "CB129",
    "type": "checkbox",
    "page": 4,
    "field_label": "leptomeningeal metastases from lymphoma",
    "question": "Is the patient's central nervous system lymphoma characterized by leptomeningeal metastases?",
    "context": "Specific subtype of CNS lymphoma, informing treatment approach."
  },
  "CB130": {
    "name": "CB130",
    "type": "checkbox",
    "page": 4,
    "field_label": "primary CNS lymphoma",
    "question": "Does the patient have primary CNS lymphoma?",
    "context": "Specific subtype of CNS lymphoma, informing treatment approach."
  },
  "CB131": {
    "name": "CB131",
    "type": "checkbox",
    "page": 4,
    "field_label": "none of the above",
    "question": "Are none of the listed central nervous system lymphoma types applicable to the patient?",
    "context": "Indicates the patient's CNS lymphoma type is not among the specified options."
  },
  "CB132": {
    "name": "CB132",
    "type": "checkbox",
    "page": 4,
    "field_label": "chronic lymphocytic leukemia (CLL)",
    "question": "Does the patient have chronic lymphocytic leukemia (CLL)?",
    "context": "Specific subtype of leukemia for treatment eligibility assessment."
  },
  "CB133": {
    "name": "CB133",
    "type": "checkbox",
    "page": 4,
    "field_label": "small lymphocytic leukemia",
    "question": "Does the patient have small lymphocytic leukemia?",
    "context": "Specific subtype of leukemia for treatment eligibility assessment."
  },
  "CB134": {
    "name": "CB134",
    "type": "checkbox",
    "page": 4,
    "field_label": "none of the above",
    "question": "Are none of the listed chronic or small lymphocytic leukemia types applicable to the patient?",
    "context": "Indicates the patient's leukemia type is not among the specified options."
  },
  "CB135": {
    "name": "CB135",
    "type": "checkbox",
    "page": 4,
    "field_label": "Yes",
    "question": "Does the patient have a documented diagnosis of cryoglobulinemia?",
    "context": "Clinical criteria for cryoglobulinemia diagnosis, required for treatment approval."
  },
  "CB136": {
    "name": "CB136",
    "type": "checkbox",
    "page": 4,
    "field_label": "No",
    "question": "Does the patient not have a documented diagnosis of cryoglobulinemia?",
    "context": "Indicates absence of cryoglobulinemia, affecting treatment eligibility."
  },
  "CB139": {
    "name": "CB139",
    "type": "checkbox",
    "page": 4,
    "field_label": "Yes",
    "question": "Is there clinical documentation that treatment with corticosteroids and other immunosuppressive agents was ineffective for cryoglobulinemia?",
    "context": "Required for prior authorization if standard therapies have failed for cryoglobulinemia."
  },
  "CB140": {
    "name": "CB140",
    "type": "checkbox",
    "page": 4,
    "field_label": "No",
    "question": "Is there no clinical documentation that treatment with corticosteroids and other immunosuppressive agents was ineffective for cryoglobulinemia?",
    "context": "Indicates if standard therapies have not failed for cryoglobulinemia."
  },
  "CB144": {
    "name": "CB144",
    "type": "checkbox",
    "page": 4,
    "field_label": "Yes",
    "question": "Is there documentation that Rituxan (rituximab) is being used as last-resort treatment for chronic graft versus host disease (GVHD)?",
    "context": "Indicates the patient's medical necessity for Rituxan after other therapies have failed for GVHD."
  },
  "CB145": {
    "name": "CB145",
    "type": "checkbox",
    "page": 4,
    "field_label": "No",
    "question": "Is there no documentation that Rituxan (rituximab) is being used as last-resort treatment for chronic graft versus host disease (GVHD)?",
    "context": "Indicates if Rituxan is not being used as a last-resort treatment for GVHD."
  },
  "CB141": {
    "name": "CB141",
    "type": "checkbox",
    "page": 4,
    "field_label": "relapsed hairy cell leukemia",
    "question": "Does the patient have relapsed hairy cell leukemia?",
    "context": "Specific stage of hairy cell leukemia, affecting treatment protocol."
  },
  "CB142": {
    "name": "CB142",
    "type": "checkbox",
    "page": 4,
    "field_label": "refractory hairy cell leukemia",
    "question": "Does the patient have refractory hairy cell leukemia?",
    "context": "Specific stage of hairy cell leukemia, affecting treatment protocol."
  },
  "CB143": {
    "name": "CB143",
    "type": "checkbox",
    "page": 4,
    "field_label": "none of the above",
    "question": "Are none of the listed hairy cell leukemia types applicable to the patient?",
    "context": "Indicates the patient's hairy cell leukemia type is not among the specified options."
  },
  "CB137": {
    "name": "CB137",
    "type": "checkbox",
    "page": 4,
    "field_label": "Yes",
    "question": "Is there documentation that Rituxan (rituximab) is being used for treatment or prevention of antibody mediated rejection in heart or other solid organ transplant recipients?",
    "context": "Clinical justification for Rituxan use in transplant patients, addressing rejection."
  },
  "CB146": {
    "name": "CB146",
    "type": "checkbox",
    "page": 4,
    "field_label": "heart transplant recipient",
    "question": "Is the patient a heart transplant recipient?",
    "context": "Specific type of organ transplant, indicating clinical context for Rituxan use."
  },
  "CB147": {
    "name": "CB147",
    "type": "checkbox",
    "page": 4,
    "field_label": "other solid organ transplant recipient",
    "question": "Is the patient an other solid organ transplant recipient?",
    "context": "Specific type of organ transplant, indicating clinical context for Rituxan use."
  },
  "CB138": {
    "name": "CB138",
    "type": "checkbox",
    "page": 4,
    "field_label": "No",
    "question": "Is there no documentation that Rituxan (rituximab) is being used for treatment or prevention of antibody mediated rejection in heart or other solid organ transplant recipients?",
    "context": "Indicates if Rituxan is not being used for transplant rejection treatment or prevention."
  },
  "CB148": {
    "name": "CB148",
    "type": "checkbox",
    "page": 4,
    "field_label": "Bavencio (avelumab)",
    "question": "Was Bavencio (avelumab) the immune checkpoint inhibitor that caused the encephalitis?",
    "context": "Identifies the specific immune checkpoint inhibitor related to the encephalitis."
  },
  "CB149": {
    "name": "CB149",
    "type": "checkbox",
    "page": 4,
    "field_label": "Imfinzi (durvalumab)",
    "question": "Was Imfinzi (durvalumab) the immune checkpoint inhibitor that caused the encephalitis?",
    "context": "Identifies the specific immune checkpoint inhibitor related to the encephalitis."
  },
  "CB150": {
    "name": "CB150",
    "type": "checkbox",
    "page": 4,
    "field_label": "Keytruda (pembrolizumab)",
    "question": "Was Keytruda (pembrolizumab) the immune checkpoint inhibitor that caused the encephalitis?",
    "context": "Identifies the specific immune checkpoint inhibitor related to the encephalitis."
  },
  "CB151": {
    "name": "CB151",
    "type": "checkbox",
    "page": 4,
    "field_label": "Opdivo (nivolumab)",
    "question": "Was Opdivo (nivolumab) the immune checkpoint inhibitor that caused the encephalitis?",
    "context": "Identifies the specific immune checkpoint inhibitor related to the encephalitis."
  },
  "CB152": {
    "name": "CB152",
    "type": "checkbox",
    "page": 4,
    "field_label": "Tecentriq (atezolizumab)",
    "question": "Was Tecentriq (atezolizumab) the immune checkpoint inhibitor that caused the encephalitis?",
    "context": "Identifies the specific immune checkpoint inhibitor related to the encephalitis."
  },
  "CB153": {
    "name": "CB153",
    "type": "checkbox",
    "page": 4,
    "field_label": "Yervoy (ipilimumab)",
    "question": "Was Yervoy (ipilimumab) the immune checkpoint inhibitor that caused the encephalitis?",
    "context": "Identifies the specific immune checkpoint inhibitor related to the encephalitis."
  },
  "CB154": {
    "name": "CB154",
    "type": "checkbox",
    "page": 4,
    "field_label": "Other:",
    "question": "Was an 'Other' immune checkpoint inhibitor the cause of the encephalitis?",
    "context": "Allows specification of an immune checkpoint inhibitor not explicitly listed."
  },
  "T155": {
    "name": "T155",
    "type": "text",
    "page": 4,
    "field_label": "Other:",
    "question": "Please specify the 'Other' immune checkpoint inhibitor that caused the encephalitis.",
    "context": "Text field to capture the name of the 'Other' immune checkpoint inhibitor for specificity."
  },
  "CB156": {
    "name": "CB156",
    "type": "checkbox",
    "page": 4,
    "field_label": "Yes",
    "question": "Does the patient have a documented diagnosis of refractory immune or idiopathic thrombocytopenic purpura (ITP)?",
    "context": "Clinical criteria for ITP diagnosis, crucial for determining treatment necessity."
  },
  "CB158": {
    "name": "CB158",
    "type": "checkbox",
    "page": 4,
    "field_label": "refractory immune thrombocytopenic purpura",
    "question": "Does the patient have refractory immune thrombocytopenic purpura?",
    "context": "Specific sub-type of ITP, impacting treatment choice and rationale."
  },
  "CB159": {
    "name": "CB159",
    "type": "checkbox",
    "page": 4,
    "field_label": "idiopathic thrombocytopenic purpura (ITP)",
    "question": "Does the patient have idiopathic thrombocytopenic purpura (ITP)?",
    "context": "Specific sub-type of ITP, impacting treatment choice and rationale."
  },
  "CB157": {
    "name": "CB157",
    "type": "checkbox",
    "page": 4,
    "field_label": "No",
    "question": "Does the patient not have a documented diagnosis of refractory immune or idiopathic thrombocytopenic purpura (ITP)?",
    "context": "Indicates absence of ITP diagnosis, affecting treatment eligibility."
  },
  "CB160": {
    "name": "CB160",
    "type": "checkbox",
    "page": 4,
    "field_label": "Yes",
    "question": "Is Rituxan (rituximab) being used as rejection prophylaxis in sensitized kidney transplant recipients with donor specific antibodies?",
    "context": "Indicates Rituxan's use in preventing organ rejection in high-risk kidney transplant patients."
  },
  "CB161": {
    "name": "CB161",
    "type": "checkbox",
    "page": 4,
    "field_label": "No",
    "question": "Is Rituxan (rituximab) not being used as rejection prophylaxis in sensitized kidney transplant recipients with donor specific antibodies?",
    "context": "Indicates if Rituxan is not being used for kidney transplant rejection prophylaxis."
  },
  "CB162": {
    "name": "CB162",
    "type": "checkbox",
    "page": 4,
    "field_label": "Yes",
    "question": "Does the patient have a documented diagnosis of lymphocyte-predominant Hodgkin's lymphoma?",
    "context": "Clinical criteria for lymphocyte-predominant Hodgkin's lymphoma, critical for authorization."
  },
  "CB163": {
    "name": "CB163",
    "type": "checkbox",
    "page": 4,
    "field_label": "No",
    "question": "Does the patient not have a documented diagnosis of lymphocyte-predominant Hodgkin's lymphoma?",
    "context": "Indicates absence of lymphocyte-predominant Hodgkin's lymphoma diagnosis."
  },
  "CB164": {
    "name": "CB164",
    "type": "checkbox",
    "page": 4,
    "field_label": "Relapsing-remitting MS (RRMS)",
    "question": "Does the patient have Relapsing-remitting MS (RRMS)?",
    "context": "Specific subtype of Multiple Sclerosis, guiding appropriate treatment selection."
  },
  "CB165": {
    "name": "CB165",
    "type": "checkbox",
    "page": 4,
    "field_label": "Secondary-progressive MS (SPMS)",
    "question": "Does the patient have Secondary-progressive MS (SPMS)?",
    "context": "Specific subtype of Multiple Sclerosis, guiding appropriate treatment selection."
  },
  "CB166": {
    "name": "CB166",
    "type": "checkbox",
    "page": 4,
    "field_label": "Primary-progressive MS (PPMS)",
    "question": "Does the patient have Primary-progressive MS (PPMS)?",
    "context": "Specific subtype of Multiple Sclerosis, guiding appropriate treatment selection."
  },
  "CB167": {
    "name": "CB167",
    "type": "checkbox",
    "page": 4,
    "field_label": "Progressive-relapsing MS (PRMS)",
    "question": "Does the patient have Progressive-relapsing MS (PRMS)?",
    "context": "Specific subtype of Multiple Sclerosis, guiding appropriate treatment selection."
  },
  "CB168": {
    "name": "CB168",
    "type": "checkbox",
    "page": 4,
    "field_label": "Yes",
    "question": "Has the patient discontinued other medications used for treating MS (not including Ampyra)?",
    "context": "Checks for prior medication history for MS, indicating treatment progression or failure."
  },
  "CB169": {
    "name": "CB169",
    "type": "checkbox",
    "page": 4,
    "field_label": "No",
    "question": "Has the patient not discontinued other medications used for treating MS (not including Ampyra)?",
    "context": "Indicates if previous MS medications are still being used or not discontinued."
  },
  "CB170": {
    "name": "CB170",
    "type": "checkbox",
    "page": 4,
    "field_label": "Yes",
    "question": "Does the patient have a documented diagnosis of muscle-specific tyrosine kinase myasthenia gravis (MuSK-MG)?",
    "context": "Clinical criteria for MuSK-MG diagnosis, required for treatment approval."
  },
  "CB172": {
    "name": "CB172",
    "type": "checkbox",
    "page": 4,
    "field_label": "Yes",
    "question": "Has the patient had an unsatisfactory response to initial immunotherapy for MuSK-MG?",
    "context": "Evaluates prior treatment effectiveness for MuSK-MG, justifying alternative therapies."
  },
  "CB173": {
    "name": "CB173",
    "type": "checkbox",
    "page": 4,
    "field_label": "No",
    "question": "Has the patient not had an unsatisfactory response to initial immunotherapy for MuSK-MG?",
    "context": "Indicates if initial immunotherapy for MuSK-MG was satisfactory."
  },
  "CB171": {
    "name": "CB171",
    "type": "checkbox",
    "page": 4,
    "field_label": "No",
    "question": "Does the patient not have a documented diagnosis of muscle-specific tyrosine kinase myasthenia gravis (MuSK-MG)?",
    "context": "Indicates absence of MuSK-MG diagnosis, affecting treatment eligibility."
  },
  "CB174": {
    "name": "CB174",
    "type": "checkbox",
    "page": 4,
    "field_label": "Yes",
    "question": "Does the patient have a documented diagnosis of neuromyelitis optica (Devic's disease)?",
    "context": "Clinical criteria for Devic's disease diagnosis, essential for treatment justification."
  },
  "CB175": {
    "name": "CB175",
    "type": "checkbox",
    "page": 4,
    "field_label": "No",
    "question": "Does the patient not have a documented diagnosis of neuromyelitis optica (Devic's disease)?",
    "context": "Indicates absence of Devic's disease diagnosis, affecting treatment eligibility."
  },
  "CB176": {
    "name": "CB176",
    "type": "checkbox",
    "page": 4,
    "field_label": "Yes",
    "question": "Was the treatment with at least one immunotherapy ineffective for neuromyelitis optica?",
    "context": "Evaluates prior treatment effectiveness for Devic's disease, supporting new therapy."
  },
  "CB177": {
    "name": "CB177",
    "type": "checkbox",
    "page": 4,
    "field_label": "No",
    "question": "Was the treatment with at least one immunotherapy not ineffective for neuromyelitis optica?",
    "context": "Indicates if previous immunotherapy for neuromyelitis optica was effective."
  },
  "CB178": {
    "name": "CB178",
    "type": "checkbox",
    "page": 4,
    "field_label": "Yes",
    "question": "Does the patient have a documented diagnosis of opsoclonus-myoclonus-ataxia (OMA) associated with neuroblastoma?",
    "context": "Clinical criteria for OMA diagnosis with neuroblastoma, relevant for treatment."
  },
  "CB179": {
    "name": "CB179",
    "type": "checkbox",
    "page": 4,
    "field_label": "No",
    "question": "Does the patient not have a documented diagnosis of opsoclonus-myoclonus-ataxia (OMA) associated with neuroblastoma?",
    "context": "Indicates absence of OMA diagnosis with neuroblastoma."
  },
  "CB180": {
    "name": "CB180",
    "type": "checkbox",
    "page": 4,
    "field_label": "Yes",
    "question": "Is the patient refractory to steroids, chemotherapy and intravenous immunoglobulins for OMA?",
    "context": "Indicates failure of standard OMA treatments, justifying alternative or advanced therapy."
  },
  "T189": {
    "name": "T189",
    "type": "text",
    "page": 4,
    "field_label": "Medication:",
    "question": "What was the name of the first medication tried for opsoclonus-myoclonus-ataxia?",
    "context": "Name of medication used to treat OMA, providing historical treatment data."
  },
  "T190": {
    "name": "T190",
    "type": "text",
    "page": 4,
    "field_label": "Date: (MM)",
    "question": "What is the start month (MM) for the first medication tried for opsoclonus-myoclonus-ataxia?",
    "context": "Start month of the first medication used for OMA, for treatment duration assessment."
  },
  "T191": {
    "name": "T191",
    "type": "text",
    "page": 4,
    "field_label": "Date: (DD)",
    "question": "What is the start day (DD) for the first medication tried for opsoclonus-myoclonus-ataxia?",
    "context": "Start day of the first medication used for OMA, for treatment duration assessment."
  },
  "T192": {
    "name": "T192",
    "type": "text",
    "page": 4,
    "field_label": "Date: (YYYY)",
    "question": "What is the start year (YYYY) for the first medication tried for opsoclonus-myoclonus-ataxia?",
    "context": "Start year of the first medication used for OMA, for treatment duration assessment."
  },
  "T193": {
    "name": "T193",
    "type": "text",
    "page": 4,
    "field_label": "Date: (MM)",
    "question": "What is the end month (MM) for the first medication tried for opsoclonus-myoclonus-ataxia?",
    "context": "End month of the first medication used for OMA, for treatment duration assessment."
  },
  "T194": {
    "name": "T194",
    "type": "text",
    "page": 4,
    "field_label": "Date: (DD)",
    "question": "What is the end day (DD) for the first medication tried for opsoclonus-myoclonus-ataxia?",
    "context": "End day of the first medication used for OMA, for treatment duration assessment."
  },
  "T195": {
    "name": "T195",
    "type": "text",
    "page": 4,
    "field_label": "Date: (YYYY)",
    "question": "What is the end year (YYYY) for the first medication tried for opsoclonus-myoclonus-ataxia?",
    "context": "End year of the first medication used for OMA, for treatment duration assessment."
  },
  "T196": {
    "name": "T196",
    "type": "text",
    "page": 4,
    "field_label": "Medication:",
    "question": "What was the name of the second medication tried for opsoclonus-myoclonus-ataxia?",
    "context": "Name of second medication used to treat OMA, providing historical treatment data."
  },
  "T197": {
    "name": "T197",
    "type": "text",
    "page": 4,
    "field_label": "Date: (MM)",
    "question": "What is the start month (MM) for the second medication tried for opsoclonus-myoclonus-ataxia?",
    "context": "Start month of the second medication used for OMA, for treatment duration assessment."
  },
  "T198": {
    "name": "T198",
    "type": "text",
    "page": 4,
    "field_label": "Date: (DD)",
    "question": "What is the start day (DD) for the second medication tried for opsoclonus-myoclonus-ataxia?",
    "context": "Start day of the second medication used for OMA, for treatment duration assessment."
  },
  "T199": {
    "name": "T199",
    "type": "text",
    "page": 4,
    "field_label": "Date: (YYYY)",
    "question": "What is the start year (YYYY) for the second medication tried for opsoclonus-myoclonus-ataxia?",
    "context": "Start year of the second medication used for OMA, for treatment duration assessment."
  },
  "T200": {
    "name": "T200",
    "type": "text",
    "page": 4,
    "field_label": "Date: (MM)",
    "question": "What is the end month (MM) for the second medication tried for opsoclonus-myoclonus-ataxia?",
    "context": "End month of the second medication used for OMA, for treatment duration assessment."
  },
  "T201": {
    "name": "T201",
    "type": "text",
    "page": 4,
    "field_label": "Date: (DD)",
    "question": "What is the end day (DD) for the second medication tried for opsoclonus-myoclonus-ataxia?",
    "context": "End day of the second medication used for OMA, for treatment duration assessment."
  },
  "T202": {
    "name": "T202",
    "type": "text",
    "page": 4,
    "field_label": "Date: (YYYY)",
    "question": "What is the end year (YYYY) for the second medication tried for opsoclonus-myoclonus-ataxia?",
    "context": "End year of the second medication used for OMA, for treatment duration assessment."
  },
  "CB181": {
    "name": "CB181",
    "type": "checkbox",
    "page": 4,
    "field_label": "No",
    "question": "Is the patient not refractory to steroids, chemotherapy and intravenous immunoglobulins for OMA?",
    "context": "Indicates if standard OMA treatments (steroids, chemo, IVIG) have been effective."
  },
  "CB203": {
    "name": "CB203",
    "type": "checkbox",
    "page": 4,
    "field_label": "Yes",
    "question": "Is Rituxan (rituximab) being used as treatment of post-transplant lymphoproliferative disorder?",
    "context": "Justifies Rituxan use for treating PTLD, ensuring medical necessity."
  },
  "CB204": {
    "name": "CB204",
    "type": "checkbox",
    "page": 4,
    "field_label": "No",
    "question": "Is Rituxan (rituximab) not being used as treatment of post-transplant lymphoproliferative disorder?",
    "context": "Indicates if Rituxan is not being used to treat post-transplant lymphoproliferative disorder."
  },
  "CB205": {
    "name": "CB205",
    "type": "checkbox",
    "page": 4,
    "field_label": "Yes",
    "question": "Is Rituxan (rituximab) being used as prophylaxis for Epstein-Barr virus (EBV) post-transplant lymphoproliferative disorder?",
    "context": "Justifies Rituxan use for preventing EBV-associated PTLD, ensuring medical necessity."
  },
  "CB206": {
    "name": "CB206",
    "type": "checkbox",
    "page": 4,
    "field_label": "No",
    "question": "Is Rituxan (rituximab) not being used as prophylaxis for Epstein-Barr virus (EBV) post-transplant lymphoproliferative disorder?",
    "context": "Indicates if Rituxan is not being used for EBV-related PTLD prophylaxis."
  },
  "CB207": {
    "name": "CB207",
    "type": "checkbox",
    "page": 5,
    "field_label": "Mild",
    "question": "Is the patient's rheumatoid arthritis disease severity mild?",
    "context": "Clinical information for Rheumatoid Arthritis, used to assess disease severity at the time of the request."
  },
  "CB208": {
    "name": "CB208",
    "type": "checkbox",
    "page": 5,
    "field_label": "Moderate",
    "question": "Is the patient's rheumatoid arthritis disease severity moderate?",
    "context": "Clinical information for Rheumatoid Arthritis, used to assess disease severity at the time of the request."
  },
  "CB209": {
    "name": "CB209",
    "type": "checkbox",
    "page": 5,
    "field_label": "Severe",
    "question": "Is the patient's rheumatoid arthritis disease severity severe?",
    "context": "Clinical information for Rheumatoid Arthritis, used to assess disease severity at the time of the request."
  },
  "CB210": {
    "name": "CB210",
    "type": "checkbox",
    "page": 5,
    "field_label": "Yes",
    "question": "Is there evidence that the rheumatoid arthritis disease is active?",
    "context": "Primary clinical question for Rheumatoid Arthritis, indicating active disease state justifying treatment."
  },
  "CB211": {
    "name": "CB211",
    "type": "checkbox",
    "page": 5,
    "field_label": "No",
    "question": "Is there no evidence that the rheumatoid arthritis disease is active?",
    "context": "Primary clinical question for Rheumatoid Arthritis, indicating no active disease state."
  },
  "CB212": {
    "name": "CB212",
    "type": "checkbox",
    "page": 5,
    "field_label": "Yes",
    "question": "Will Rituxan (rituximab) be used in combination with methotrexate?",
    "context": "Sub-question for Rheumatoid Arthritis regarding concomitant therapy with methotrexate."
  },
  "CB213": {
    "name": "CB213",
    "type": "checkbox",
    "page": 5,
    "field_label": "No",
    "question": "Will Rituxan (rituximab) not be used in combination with methotrexate?",
    "context": "Sub-question for Rheumatoid Arthritis regarding concomitant therapy with methotrexate."
  },
  "CB214": {
    "name": "CB214",
    "type": "checkbox",
    "page": 5,
    "field_label": "Yes",
    "question": "Was treatment with methotrexate ineffective, not tolerated or contraindicated?",
    "context": "Sub-question for Rheumatoid Arthritis, assessing the outcome of prior methotrexate therapy."
  },
  "CB216": {
    "name": "CB216",
    "type": "checkbox",
    "page": 5,
    "field_label": "ineffective",
    "question": "Was methotrexate treatment ineffective?",
    "context": "Reason for methotrexate failure in Rheumatoid Arthritis, determining eligibility for Rituxan based on prior therapy response."
  },
  "CB217": {
    "name": "CB217",
    "type": "checkbox",
    "page": 5,
    "field_label": "not tolerated",
    "question": "Was methotrexate treatment not tolerated?",
    "context": "Reason for methotrexate failure in Rheumatoid Arthritis, determining eligibility for Rituxan based on patient tolerance."
  },
  "CB218": {
    "name": "CB218",
    "type": "checkbox",
    "page": 5,
    "field_label": "contraindicated",
    "question": "Was methotrexate treatment contraindicated?",
    "context": "Reason for methotrexate failure in Rheumatoid Arthritis, determining eligibility for Rituxan based on contraindications."
  },
  "CB215": {
    "name": "CB215",
    "type": "checkbox",
    "page": 5,
    "field_label": "No",
    "question": "Was methotrexate treatment not ineffective, tolerated, or not contraindicated?",
    "context": "Sub-question for Rheumatoid Arthritis, indicating no issues with prior methotrexate therapy."
  },
  "CB223": {
    "name": "CB223",
    "type": "checkbox",
    "page": 5,
    "field_label": "Yes",
    "question": "Was treatment with another conventional DMARD ineffective?",
    "context": "Sub-question for Rheumatoid Arthritis, assessing the outcome of prior conventional DMARD therapy."
  },
  "CB225": {
    "name": "CB225",
    "type": "checkbox",
    "page": 5,
    "field_label": "azathioprine",
    "question": "Was azathioprine an ineffective conventional DMARD?",
    "context": "Specific conventional DMARD failed for Rheumatoid Arthritis, influencing approval for Rituxan."
  },
  "CB226": {
    "name": "CB226",
    "type": "checkbox",
    "page": 5,
    "field_label": "cyclosporine",
    "question": "Was cyclosporine an ineffective conventional DMARD?",
    "context": "Specific conventional DMARD failed for Rheumatoid Arthritis, influencing approval for Rituxan."
  },
  "CB227": {
    "name": "CB227",
    "type": "checkbox",
    "page": 5,
    "field_label": "hydroxychloroquine",
    "question": "Was hydroxychloroquine an ineffective conventional DMARD?",
    "context": "Specific conventional DMARD failed for Rheumatoid Arthritis, influencing approval for Rituxan."
  },
  "CB228": {
    "name": "CB228",
    "type": "checkbox",
    "page": 5,
    "field_label": "leflunomide",
    "question": "Was leflunomide an ineffective conventional DMARD?",
    "context": "Specific conventional DMARD failed for Rheumatoid Arthritis, influencing approval for Rituxan."
  },
  "CB229": {
    "name": "CB229",
    "type": "checkbox",
    "page": 5,
    "field_label": "sulfasalazine",
    "question": "Was sulfasalazine an ineffective conventional DMARD?",
    "context": "Specific conventional DMARD failed for Rheumatoid Arthritis, influencing approval for Rituxan."
  },
  "CB224": {
    "name": "CB224",
    "type": "checkbox",
    "page": 5,
    "field_label": "No",
    "question": "Was treatment with another conventional DMARD not ineffective?",
    "context": "Sub-question for Rheumatoid Arthritis, indicating no issues with other conventional DMARD therapy."
  },
  "CB281": {
    "name": "CB281",
    "type": "checkbox",
    "page": 5,
    "field_label": "Yes",
    "question": "Does the patient have a documented diagnosis of Sjögren's syndrome?",
    "context": "Primary clinical question for Sjögren syndrome, confirming the patient's diagnosis."
  },
  "CB282": {
    "name": "CB282",
    "type": "checkbox",
    "page": 5,
    "field_label": "No",
    "question": "Does the patient not have a documented diagnosis of Sjögren's syndrome?",
    "context": "Primary clinical question for Sjögren syndrome, confirming absence of diagnosis."
  },
  "CB283": {
    "name": "CB283",
    "type": "checkbox",
    "page": 5,
    "field_label": "Yes",
    "question": "Was treatment with corticosteroids and other immunosuppressive agents ineffective for Sjögren's syndrome?",
    "context": "Sub-question for Sjögren syndrome, assessing prior therapy response to standard agents."
  },
  "T285": {
    "name": "T285",
    "type": "text",
    "page": 5,
    "field_label": "Medication:",
    "question": "What is the name of the corticosteroid or immunosuppressive agent that was used?",
    "context": "Details for Sjögren syndrome, specifying the prior medication that was ineffective."
  },
  "T286": {
    "name": "T286",
    "type": "text",
    "page": 5,
    "field_label": "Date: (MM)",
    "question": "What is the month of administration for the first specified medication?",
    "context": "Date of administration for failed Sjögren's medication, detailing the timeline of prior therapy."
  },
  "T287": {
    "name": "T287",
    "type": "text",
    "page": 5,
    "field_label": "Date: (DD)",
    "question": "What is the day of administration for the first specified medication?",
    "context": "Date of administration for failed Sjögren's medication, detailing the timeline of prior therapy."
  },
  "T288": {
    "name": "T288",
    "type": "text",
    "page": 5,
    "field_label": "Date: (YYYY)",
    "question": "What is the year of administration for the first specified medication?",
    "context": "Date of administration for failed Sjögren's medication, detailing the timeline of prior therapy."
  },
  "T289": {
    "name": "T289",
    "type": "text",
    "page": 5,
    "field_label": "Date: (MM)",
    "question": "What is the month of administration for the second specified medication?",
    "context": "Date of administration for failed Sjögren's medication, detailing the timeline of prior therapy."
  },
  "T290": {
    "name": "T290",
    "type": "text",
    "page": 5,
    "field_label": "Date: (DD)",
    "question": "What is the day of administration for the second specified medication?",
    "context": "Date of administration for failed Sjögren's medication, detailing the timeline of prior therapy."
  },
  "T291": {
    "name": "T291",
    "type": "text",
    "page": 5,
    "field_label": "Date: (YYYY)",
    "question": "What is the year of administration for the second specified medication?",
    "context": "Date of administration for failed Sjögren's medication, detailing the timeline of prior therapy."
  },
  "T292": {
    "name": "T292",
    "type": "text",
    "page": 5,
    "field_label": "Medication:",
    "question": "What is the name of the second corticosteroid or immunosuppressive agent that was used?",
    "context": "Details for Sjögren syndrome, specifying the second prior medication that was ineffective."
  },
  "T293": {
    "name": "T293",
    "type": "text",
    "page": 5,
    "field_label": "Date: (MM)",
    "question": "What is the month of administration for the third specified medication?",
    "context": "Date of administration for failed Sjögren's medication, detailing the timeline of prior therapy."
  },
  "T294": {
    "name": "T294",
    "type": "text",
    "page": 5,
    "field_label": "Date: (DD)",
    "question": "What is the day of administration for the third specified medication?",
    "context": "Date of administration for failed Sjögren's medication, detailing the timeline of prior therapy."
  },
  "T295": {
    "name": "T295",
    "type": "text",
    "page": 5,
    "field_label": "Date: (YYYY)",
    "question": "What is the year of administration for the third specified medication?",
    "context": "Date of administration for failed Sjögren's medication, detailing the timeline of prior therapy."
  },
  "T296": {
    "name": "T296",
    "type": "text",
    "page": 5,
    "field_label": "Date: (MM)",
    "question": "What is the month of administration for the fourth specified medication?",
    "context": "Date of administration for failed Sjögren's medication, detailing the timeline of prior therapy."
  },
  "T297": {
    "name": "T297",
    "type": "text",
    "page": 5,
    "field_label": "Date: (DD)",
    "question": "What is the day of administration for the fourth specified medication?",
    "context": "Date of administration for failed Sjögren's medication, detailing the timeline of prior therapy."
  },
  "T298": {
    "name": "T298",
    "type": "text",
    "page": 5,
    "field_label": "Date: (YYYY)",
    "question": "What is the year of administration for the fourth specified medication?",
    "context": "Date of administration for failed Sjögren's medication, detailing the timeline of prior therapy."
  },
  "CB284": {
    "name": "CB284",
    "type": "checkbox",
    "page": 5,
    "field_label": "No",
    "question": "Was treatment with corticosteroids and other immunosuppressive agents not ineffective for Sjögren's syndrome?",
    "context": "Sub-question for Sjögren syndrome, indicating prior therapy with standard agents was effective."
  },
  "CB299": {
    "name": "CB299",
    "type": "checkbox",
    "page": 5,
    "field_label": "Yes",
    "question": "Does the patient have a documented diagnosis of refractory thrombotic thrombocytopenic purpura (TTP)?",
    "context": "Primary clinical question for TTP, confirming diagnosis for potential Rituxan use."
  },
  "CB300": {
    "name": "CB300",
    "type": "checkbox",
    "page": 5,
    "field_label": "No",
    "question": "Does the patient not have a documented diagnosis of refractory thrombotic thrombocytopenic purpura (TTP)?",
    "context": "Primary clinical question for TTP, indicating absence of diagnosis for Rituxan coverage."
  },
  "CB301": {
    "name": "CB301",
    "type": "checkbox",
    "page": 5,
    "field_label": "Yes",
    "question": "Does the patient have a documented diagnosis of Waldenström macroglobulinemia?",
    "context": "Primary clinical question for Waldenström's macroglobulinemia, confirming diagnosis for Rituxan coverage."
  },
  "CB302": {
    "name": "CB302",
    "type": "checkbox",
    "page": 5,
    "field_label": "No",
    "question": "Does the patient not have a documented diagnosis of Waldenström macroglobulinemia?",
    "context": "Primary clinical question for Waldenström's macroglobulinemia, indicating absence of diagnosis."
  },
  "CB303": {
    "name": "CB303",
    "type": "checkbox",
    "page": 5,
    "field_label": "Yes",
    "question": "Is this continuation request a result of the patient receiving samples of Rituxan (rituximab)?",
    "context": "Continuation request detail, clarifying if the current therapy started with sample medication."
  },
  "CB304": {
    "name": "CB304",
    "type": "checkbox",
    "page": 5,
    "field_label": "No",
    "question": "Is this continuation request not a result of the patient receiving samples of Rituxan (rituximab)?",
    "context": "Continuation request detail, clarifying if the current therapy did not start with sample medication."
  },
  "T305": {
    "name": "T305",
    "type": "text",
    "page": 5,
    "field_label": "Please indicate the length of time on Rituxan (rituximab):",
    "question": "What is the length of time the patient has been on Rituxan (rituximab)?",
    "context": "Continuation request detail, specifying duration of current Rituxan therapy for ongoing approval."
  },
  "CB310": {
    "name": "CB310",
    "type": "checkbox",
    "page": 5,
    "field_label": "Mild",
    "question": "Was the severity of the rheumatoid arthritis disease at baseline (pretreatment with Rituxan (rituximab)) mild?",
    "context": "Baseline severity assessment for Rheumatoid Arthritis in continuation requests, used to track treatment efficacy."
  },
  "CB311": {
    "name": "CB311",
    "type": "checkbox",
    "page": 5,
    "field_label": "Moderate",
    "question": "Was the severity of the rheumatoid arthritis disease at baseline (pretreatment with Rituxan (rituximab)) moderate?",
    "context": "Baseline severity assessment for Rheumatoid Arthritis in continuation requests, used to track treatment efficacy."
  },
  "CB312": {
    "name": "CB312",
    "type": "checkbox",
    "page": 5,
    "field_label": "Severe",
    "question": "Was the severity of the rheumatoid arthritis disease at baseline (pretreatment with Rituxan (rituximab)) severe?",
    "context": "Baseline severity assessment for Rheumatoid Arthritis in continuation requests, used to track treatment efficacy."
  },
  "CB306": {
    "name": "CB306",
    "type": "checkbox",
    "page": 5,
    "field_label": "Yes",
    "question": "Is there clinical documentation supporting disease stability for rheumatoid arthritis?",
    "context": "Clinical information for Rheumatoid Arthritis continuation, assessing if disease stability is documented."
  },
  "CB307": {
    "name": "CB307",
    "type": "checkbox",
    "page": 5,
    "field_label": "No",
    "question": "Is there no clinical documentation supporting disease stability for rheumatoid arthritis?",
    "context": "Clinical information for Rheumatoid Arthritis continuation, assessing if disease stability is documented."
  },
  "CB308": {
    "name": "CB308",
    "type": "checkbox",
    "page": 5,
    "field_label": "Yes",
    "question": "Is there clinical documentation supporting disease improvement for rheumatoid arthritis?",
    "context": "Clinical information for Rheumatoid Arthritis continuation, assessing if disease improvement is documented."
  },
  "CB309": {
    "name": "CB309",
    "type": "checkbox",
    "page": 5,
    "field_label": "No",
    "question": "Is there no clinical documentation supporting disease improvement for rheumatoid arthritis?",
    "context": "Clinical information for Rheumatoid Arthritis continuation, assessing if disease improvement is documented."
  },
  "CB313": {
    "name": "CB313",
    "type": "checkbox",
    "page": 5,
    "field_label": "Yes",
    "question": "Is there clinical documentation supporting disease stability for all other indications?",
    "context": "Clinical information for other indications continuation, assessing if disease stability is documented."
  },
  "CB314": {
    "name": "CB314",
    "type": "checkbox",
    "page": 5,
    "field_label": "No",
    "question": "Is there no clinical documentation supporting disease stability for all other indications?",
    "context": "Clinical information for other indications continuation, assessing if disease stability is documented."
  },
  "CB315": {
    "name": "CB315",
    "type": "checkbox",
    "page": 5,
    "field_label": "Yes",
    "question": "Is there clinical documentation supporting disease improvement for all other indications?",
    "context": "Clinical information for other indications continuation, assessing if disease improvement is documented."
  },
  "CB316": {
    "name": "CB316",
    "type": "checkbox",
    "page": 5,
    "field_label": "No",
    "question": "Is there no clinical documentation supporting disease improvement for all other indications?",
    "context": "Clinical information for other indications continuation, assessing if disease improvement is documented."
  },
  "T317": {
    "name": "T317",
    "type": "text",
    "page": 5,
    "field_label": "Date: (MM)",
    "question": "What is the month the request was completed?",
    "context": "Request completion date in the Acknowledgment section, indicating when the form was finalized and signed."
  },
  "T318": {
    "name": "T318",
    "type": "text",
    "page": 5,
    "field_label": "Date: (DD)",
    "question": "What is the day the request was completed?",
    "context": "Request completion date in the Acknowledgment section, indicating when the form was finalized and signed."
  },
  "T319": {
    "name": "T319",
    "type": "text",
    "page": 5,
    "field_label": "Date: (YYYY)",
    "question": "What is the year the request was completed?",
    "context": "Request completion date in the Acknowledgment section, indicating when the form was finalized and signed."
  }
}